Targeting Bile Acid-Activated Receptors in Bariatric Surgery.

Abstract

Bariatric surgical procedures, including Roux-en-Y gastric bypass and vertical sleeve gastrectomy, are currently the most effective clinical approaches to achieve a significant and sustainable weight loss. Bariatric surgery also concomitantly improves type 2 diabetes and other metabolic diseases such as nonalcoholic steatohepatitis, cardiovascular diseases, and hyperlipidemia. However, despite the recent exciting progress in the understanding how bariatric surgery works, the underlying molecular mechanisms of bariatric surgery remain largely unknown. Interestingly, bile acids are emerging as potential signaling molecules to mediate the beneficial effects of bariatric surgery. In this review, we summarize the recent findings on bile acids and their activated receptors in mediating the beneficial metabolic effects of bariatric surgery. We also discuss the potential to target bile acid-activated receptors in order to treat obesity and other metabolic diseases.

• Authors: Lili Ding, Zhipeng Fang, Yanjun Liu, Eryun Zhang, Tracy Huang, Li Yang, Zhengtao Wang, Wendong Huang
• Journal: Handbook of experimental pharmacology (Handb Exp Pharmacol) Vol. 256 Pg. 359-378 ( 2019) ISSN: 0171-2004 [Print] Germany
• PMID: 31144046 (Publication Type: Journal Article, Review)

Chemical References

• Bile Acids and Salts
• Receptors, Cytoplasmic and Nuclear

Topics

• Bariatric Surgery
• Bile Acids and Salts
• Diabetes Mellitus, Type 2
• Gastric Bypass
• Humans
• Receptors, Cytoplasmic and Nuclear (antagonists & inhibitors)
• Weight Loss